St. Louis Startup Spearhead Bio Raises $1.62M for New Crop Gene-Editing Tool
25 September 2026, St. Louis: Spearhead Bio, an agricultural biotechnology company based in St. Louis, Missouri, closed an oversubscribed $1.62 million seed funding round on September 17, 2026, to keep developing a gene-editing platform built to solve one of CRISPR’s most persistent technical problems: inserting large, precise pieces of new DNA into a plant’s genome without leaving foreign genetic material behind.
The round was led jointly by BioGenerator Ventures and the Danforth Technology Company, with additional investors including QRM Capital, Grit Road Partners, the St. Louis Port Authority Helix Fund and SDH Capital. It was structured as a SAFE (simple agreement for future equity), a common early-stage financing instrument that converts to shares later. Spearhead Bio spun out of the Donald Danforth Plant Science Center in 2025, and the Center’s president, Giles Oldroyd, said the science coming out of Danforth is “market-leading.”
CRISPR has become the standard tool for editing plant DNA over the past decade, largely because its Cas9 and Cas12a enzymes act like molecular scissors that can cut a gene at a precise location, which works well for disabling or removing unwanted genes. But CRISPR is far less reliable at the opposite job: inserting new genetic material of any size in a controlled way. Left to its own devices, a cut made by CRISPR tends to get repaired by the plant’s own cellular machinery in ways that insert DNA imprecisely, sometimes disrupting nearby genes in the process.
How TAHITI works
Spearhead Bio’s platform, called TAHITI (short for Transposase Assisted Homology Independent Targeted Insertion), addresses that gap by borrowing a second natural tool: transposons, sometimes called “jumping genes,” which are DNA sequences that can cut themselves out of one spot in a genome and move to another. TAHITI fuses a transposase, the enzyme that drives that movement, directly onto CRISPR’s Cas9 or Cas12a cutting enzyme. When CRISPR makes its cut, the attached transposase machinery inserts new genetic cargo directly into that break, in a controlled and repeatable way rather than at random.
The system is built as two separate components: one that carries the transposase “mover,” and another that carries the DNA “cargo” being inserted. Keeping them apart lets researchers control when and where an edit happens, and the moving machinery itself can then be bred back out, leaving only the intended edit and no foreign DNA in the finished plant. Company chief scientific officer Keith Slotkin said the funding gives the team “runway for another year and a half to two years” to hit its next technical milestones, while chief executive Mike Bielski described the platform’s range as running “everything from stacking traits to complete replacement of genes,” adding that Spearhead is “not just another CRISPR company.”
The technology has so far been demonstrated in the laboratory model plant Arabidopsis and is now being tested with industry partners in soybean and corn, including gene-replacement edits where old DNA is deleted and new DNA is inserted at the same genomic location in a single step, rather than through the multiple generations of crossing and screening that conventional breeding requires. Slotkin has described the company as “crop and trait agnostic,” meaning the underlying tool is not tied to any single crop or characteristic and could in principle be licensed for use across many species and traits.
Because TAHITI edits can be made without introducing foreign DNA, the resulting plants may avoid classification as genetically modified organisms in jurisdictions that regulate based on the presence of transgenes rather than the editing process itself, potentially shortening the regulatory path compared with older transgenic breeding methods. That distinction matters commercially: transgenic crop approvals can take years and tens of millions of dollars per trait, while several major markets now treat non-transgenic gene-edited crops more like conventionally bred varieties.
Also Read: India Approves Pioxaniliprole, First Insecticide Active Ingredient Discovered in India
Global Agriculture is an independent international media platform covering agri-business, policy, technology, and sustainability. For editorial collaborations, thought leadership, and strategic communications, write to pr@global-agriculture.com
